Zevaskyn

signing contract

Pharma

Abeona nets $155M with FDA voucher sale

As Abeona gears up for the commercial rollout of Zevaskyn, the company will have a nice chunk of cash at its disposal thanks to a PRV sale agreement.

Eric Sagonowsky May 12, 2025 9:34am

Go sign green light

Abeona enters commercial gene therapy arena with Zevaskyn FDA nod

Apr 29, 2025 9:40am